Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL) Meeting Abstract
| Authors: | Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L. |
| Abstract Title: | Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL) |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 443s |
| Language: | English |
| ACCESSION: | WOS:000276606605449 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.8540 |
| Notes: | Meeting Abstract: 8540 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
